C

CrystalGenomics Inc
KOSDAQ:083790

Watchlist Manager
CrystalGenomics Inc
KOSDAQ:083790
Watchlist
Price: 1 476 KRW 0.41%
Market Cap: 113.5B KRW

Wall Street
Price Targets

Price Targets Summary
CrystalGenomics Inc

There are no price targets for CrystalGenomics Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
CrystalGenomics Inc Competitors:
Price Targets
CYTK
Cytokinetics Inc
30% Upside
QTTB
Homology Medicines Inc
261% Upside
EDIT
Editas Medicine Inc
128% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
10% Upside
006280
Green Cross Corp
23% Upside
APLS
Apellis Pharmaceuticals Inc
44% Upside
IVA
Inventiva SA
224% Upside
SLS
Sellas Life Sciences Group Inc
145% Upside

Revenue
Forecast

Revenue Estimate
CrystalGenomics Inc

For the last 13 years the compound annual growth rate for CrystalGenomics Inc's revenue is 5%. The projected CAGR for the next 8 years is 46%.

5%
Past Growth
46%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
CrystalGenomics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
CrystalGenomics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CrystalGenomics Inc's stock price target?
Not Available

CrystalGenomics Inc doesn't have any price targets made by Wall Street professionals.

What is CrystalGenomics Inc's Revenue forecast?
Projected CAGR
46%

For the last 13 years the compound annual growth rate for CrystalGenomics Inc's revenue is 5%. The projected CAGR for the next 8 years is 46%.

Back to Top